• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Side effects of desensitization for allergy--a general practice survey.过敏脱敏治疗的副作用——一项全科医学调查
J R Coll Gen Pract. 1983 Oct;33(255):647-9.
2
Variation in examination and treatment offers to patients with allergic diseases in general practice.
Qual Prim Care. 2010;18(3):181-7.
3
[The value of immunotherapy in treatment of IgE-induced allergic diseases].[免疫疗法在治疗IgE介导的过敏性疾病中的价值]
Ther Umsch. 1994 Jan;51(1):67-76.
4
Treatment of allergy to house dust with pyridine-extracted alum-precipitated extracts of the house dust mite.用吡啶提取的屋尘螨明矾沉淀提取物治疗对屋尘的过敏反应。
Ann Allergy. 1976 Feb;36(2):95-8.
5
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001.1990 - 2001年过敏原注射和皮肤试验致死反应的12年调查
J Allergy Clin Immunol. 2004 Jun;113(6):1129-36. doi: 10.1016/j.jaci.2004.02.006.
6
[Risks of specific hyposensitization treatment].[特定脱敏治疗的风险]
Z Hautkr. 1988;63 Suppl 4:26-30.
7
Hazards with desensitising vaccines.
Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M. 1988(82):147-51.
8
Anaphylactic reactions during immunotherapy.免疫治疗期间的过敏反应。
Immunol Allergy Clin North Am. 2007 May;27(2):295-307, viii. doi: 10.1016/j.iac.2007.03.010.
9
[Allergy--triggers of life-threatening and fatal anaphylaxis].[过敏——危及生命和致命性过敏反应的触发因素]
MMW Fortschr Med. 2006 Jul 20;148(29-30):28-31.
10
Adverse effects and fatalities associated with subcutaneous allergen immunotherapy.皮下过敏原免疫疗法相关的不良反应和死亡病例
Clin Allergy Immunol. 2008;21:455-68.

引用本文的文献

1
Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement.过敏反应学诊断和治疗程序的风险与安全要求:世界过敏组织声明
World Allergy Organ J. 2016 Oct 12;9(1):33. doi: 10.1186/s40413-016-0122-3. eCollection 2016.
2
Standardized extracts, dust mite, and other arthropods (inhalants).标准化提取物、尘螨及其他节肢动物(吸入性变应原)。
Clin Rev Allergy. 1987 Feb;5(1):49-73. doi: 10.1007/BF02802257.

本文引用的文献

1
Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component.夏季花粉热和哮喘的预防:一项比较粗制草花粉提取物与分离出的主要蛋白质成分的对照试验。
Lancet. 1954 May 22;266(6821):1055-7. doi: 10.1016/s0140-6736(54)91620-7.
2
Anaphylactic reaction to desensitisation.脱敏治疗引起的过敏反应。
Br Med J. 1980 Oct 18;281(6247):1069. doi: 10.1136/bmj.281.6247.1069.
3
Anaphylactic reaction to desensitisation for allergic rhinitis and asthma.过敏性鼻炎和哮喘脱敏治疗的过敏反应。
Br Med J. 1980 Sep 27;281(6244):854. doi: 10.1136/bmj.281.6244.854.
4
A prospective national study of the safety of immunotherapy.一项关于免疫疗法安全性的前瞻性全国性研究。
Clin Allergy. 1980 Jan;10(1):59-64. doi: 10.1111/j.1365-2222.1980.tb02080.x.

过敏脱敏治疗的副作用——一项全科医学调查

Side effects of desensitization for allergy--a general practice survey.

作者信息

Rands D A, Godfrey R C

出版信息

J R Coll Gen Pract. 1983 Oct;33(255):647-9.

PMID:6644669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1973047/
Abstract

Following the unexpected death from acute anaphylaxis of a patient receiving house dust mite desensitization, general practitioners throughout Hampshire were asked about their experience of desensitization and its side effects, by means of a questionnaire. From a total of 695 doctors, 452 (65 per cent) returned valid questionnaires. Sixty-three doctors (14 per cent) did not use desensitization at all, while 20 (4 per cent) used more than 20 courses per year, mainly for patients with hay fever. The majority of doctors were modest prescribers of five or less courses per year of any one preparation. Apart from the fatal case which stimulated this enquiry, one other death was reported.

摘要

在一名接受屋尘螨脱敏治疗的患者因急性过敏反应意外死亡后,汉普郡的全科医生通过问卷调查被问及他们在脱敏治疗及其副作用方面的经验。在总共695名医生中,452名(65%)返回了有效问卷。63名医生(14%)根本不使用脱敏治疗,而20名(4%)医生每年使用超过20个疗程,主要用于治疗花粉热患者。大多数医生每年对任何一种制剂的处方量都比较适度,为五个疗程或更少。除了引发此次调查的致命病例外,还报告了另外一例死亡病例。